Answers are grounded in this paper and cite their sources.
Examining the impact of oral contraceptive (OC) dosing is important to understand how hormonal contraceptives influence ovulation, the menstrual cycle, and critically, the contraceptive state. In this paper, we develop a mechanistic mathematical model that captures hormone dynamics observed in available data. The model enables us to assess the robustness and effectiveness of various contraceptive dosing regimens, and to evaluate how the dosing strength and the schedule of hormonal OCs affect contraception. Our model incorporates the pharmacokinetics of two exogenous hormones, progestin and ethinyl estradiol (EE). We characterize the impact of dosing schedules (using daily doses with no placebo pills, 24 days of active hormone pills followed by 4 placebo days, or 21 days of active hormone pills followed by 7 placebo days) and dosing strengths on hormonal cycling dynamics. Our results show that with an increasing dose of progestin, the cycle length increases, while increasing the dose of EE removes the periodic behavior completely. We found that the no-placebo dosing schedule shows the most consistent dynamics, while regimens with placebo days had more irregular dynamics. Our model also demonstrates that two theoretical scenarios of individuals with physiologically normal menstrual cycles and the same cycle length may experience different contraceptive efficacy for the same OC dose strength and schedule. Future studies using our model may inform evidence-based dosing protocols and guide clinical decision-making, particularly in the case of missed doses.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: